Results

Total Results: 9,462 records

Showing results for "cancer".
Users also searched for: colon cancer screening

161. Statistical Brief #132
     hcup-us.ahrq.gov/reports/statbriefs/sb132.jsp
     May 01, 2012 - childhood cancers: 4 leukemias, cancer of the brain and nervous system, and cancer of the bone and … Increases were more modest for cancer of the bone and connective tissue, non-Hodgkin's lymphoma, cancers … , 21.0 percent were for cancer of the bone and connective tissue, 12.3 percent were for secondary malignancies … 21.0% Secondary malignancies 9,100 12.3% Cancer of brain and nervous system 8,800 … 1.1% Malignant neoplasm without specification of site 700 1.0% 1 Stays for children ages

162. Archived: Skin Cancer: Screening and Behavioral Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening-behavioral-counseling-1996
     January 01, 1996 - been reported. 6 , 8 With a median age at diagnosis of 53 years, 9 MM ranks second among adult-onset cancers … signs and symptoms suggesting cutaneous malignancy and the possible benefits of periodic self-examination … Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone … Model predicting survival in stage I melanoma based on tumor progression. … The effect of various sunscreen agents on skin damage and the introduction induction of tumor susceptibility

163. Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
     August 22, 2012 - and higher grade tumors. … The percentage of women with ER+ tumors was similar for the DCIS and invasive cancer groups. … Tumors larger than 1 cm and high-grade tumors were associated with higher rates of HER2 testing except … Treatment targeted to ER+ tumors is very effective for women with invasive cancers and ER testing is … HER2 testing to manage patients with breast cancer or other solid tumors.

164. Head-Neck-Cancer-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_executive.pdf
     December 01, 2014 - carcinoma of the head and neck (SCCHN) constitutes approximately 90 percent of all head and neck cancers … Cancer Institute’s Physician Data Query Cancer Information Summary.8 The definitions include cancer … Gupta et al. reported aggregated survival results in patients with tumors in different sites. … Intensity-modulated radiation therapy in head and neck cancers: an update. … Head and neck cancers. J Nat Compr Cancer Netw. 2011 Jun 1;9(6):596-650. PMID: 21636536. 9.

165. Data Points 13: Use of Preoperative Breast MRI among older women with ductal carcinoma in situ and locally invasive breast cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
     August 01, 2012 - The typical treatment for both DCIS and early invasive breast cancer is surgical removal of the tumor … Rural refers to counties with fewer than 2,500 people.15 Tumor size: We defined tumor size using the … Use was higher for women with larger or higher grade tumors. … bilateral breast cancers. … In general, women with higher risk DCIS (larger tumor size, higher grade disease, or ER-negative tumors

166. G:CIRD565TQMothers able1.PDF (pdf file)
     hcup-us.ahrq.gov/reports/natstats/his96/table1.pdf
     February 11, 2011 - Benign neoplasm of uterus [46.] 222,765 0.64 $8,551 $5,702 $7,746 $10,317 3.0 0.0 … 0.0 43.8 2.16.2 Other and unspecified benign neoplasm 151,779 0.44 $13,848 $5,700 … 2.16.2.2 Benign neoplasm of colon 26,537 0.08 $13,071 $5,756 $9,785 $15,546 5.9 … 0.7 48.5 69.4 2.16.2.3 Benign neoplasm of the thyroid 12,419 0.04 $6,806 $4,265 $5,936 … $8,074 1.7 0.0 18.6 49.3 2.16.2.4 Benign neoplasm of cerebral meninges 12,413 0.04

167. Missed breast cancers at US-guided core needle biopsy: how to reduce them. | PSNet
     psnet.ahrq.gov/issue/missed-breast-cancers-us-guided-core-needle-biopsy-how-reduce-them
     March 25, 2020 - Review Missed breast cancers at US-guided core needle biopsy: how to reduce them. … Missed breast cancers at US-guided core needle biopsy: how to reduce them. … Missed breast cancers at US-guided core needle biopsy: how to reduce them. … March 25, 2020 Changes in cancer detection and false-positive recall in mammography using … October 7, 2011 Errors in the MRI evaluation of musculoskeletal tumors and tumorlike

168. Imaging Techniques for the Surveillance, Diagnosis, and Staging of Hepatocellular Carcinoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/liver-cancer/research-protocol

169. Archived: Prostate Cancer: Screening, 2002 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2002
     December 01, 2002 - causes of this decline are uncertain. 5 Tumor grade appears to be a stronger predictor of prognosis … In studies of untreated prostate cancer, well‐differentiated tumors had low rates of metastasis or mortality … significant based on size and tumor grade, but which would not have progressed to clinical symptoms … . 3 In the absence of better data about which treatments are effective for which tumors, the USPSTF … for prostate, colorectal, and endometrial cancers.

170. Nutrition as Prevention for Improved Cancer Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
     December 01, 2021 - percent across patient populations.7-9 However, risk of malnutrition varies substantially by patient and tumor … characteristics, including age at diagnosis, tumor type, stage of disease, type of cancer treatment … (such as Head and Neck, Breast, Multiple Cancers, etc.) and report the intervention comparisons and … emia* or melanoma* or myeloma* or neoplasm* or radiotherap* or radiation therap*).ti,ab. … or exp Neoplasms/ or chemoprevention/ or chemoradiotherapy/ or chemoradiotherapy, adjuvant/ or chemotherapy

171. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
     January 01, 2024 - of prostate cancer, any malignancy diagnosed within 5 years of entry except for nonmelanoma skin cancer … (except basal cell carcinoma or other tumors within the past five years) Patients with nodal involvement … or prior pelvic RT/prostatectomy History of other malignancies (within five years, with noted exceptions … Prior malignancies, presence of small-cell, neuroendocrine or transitional-cell carcinoma in the biopsy … other than nonmetastatic skin cancers or early stage small lymphocytic lymphoma within the last 5 years

172. Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort. | PSNet
     psnet.ahrq.gov/issue/estimation-breast-cancer-overdiagnosis-us-breast-screening-cohort
     March 30, 2022 - Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort. … that 15.4% of screen-detected cancers are overdiagnosed (i.e., detecting indolent preclinical cancer … Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort. … July 6, 2022 Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis … August 10, 2011 One-stop diagnostic breast clinics: how often are breast cancers missed

173. Recommendation: Bladder Cancer in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/bladder-cancer-in-adults-screening
     August 15, 2011 - The stages of bladder cancer include superficial (Ta or T1) and muscle-invasive tumors. … Many superficial tumors (50% to 70%) will recur after treatment, with a 10% to 20% risk for the tumor … One fourth of all cases of bladder cancer and 20% to 40% of all invasive tumors have already metastasized … Treatment Once bladder cancer has been diagnosed, several factors determine treatment, including tumor … grade, cancer stage (superficial vs. invasive), whether the tumor is recurrent, the patient's age and

174. Final Recommendation Statement: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-screening
     April 30, 2024 - receptor–negative [PR–], and human epidermal growth factor receptor 2–negative [HER2–]), which are more aggressive tumors … detection or in tumor characteristics (tumor size, histologic grade, or node status) when comparing … The risk of a stage IIB or higher cancer diagnosis and of having a tumor with less favorable prognostic … cancer features such as tumor size, node positivity status, or histologic grade when comparing annual … Interval breast cancer rates and tumor characteristics in the prospective population-based Malmö breast

175. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
     December 01, 2009 - Layout 1 Background Breast cancer is the second most common malignancy of women, with over 180,000 … However, it is generally acknowledged that early diagnosis and treatment of breast tumors leads to improved … The theoretical cohort of women includes 300 women with malignant tumors and 700 women with benign lesions … Summary of key accuracy findings (Key Question 1) Number of Number of Number of malignancies invasive … missed Risk of expected per cancers cancers malignancy 1,000 biopsy expected per Strength of expected

176. Archived: Final Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary46/skin-cancer-screening-2009
     February 15, 2009 - with whole-body examination by primary care clinicians or by self-examination accurately detect skin cancers … with whole-body examination by primary care clinicians or by self-examination accurately detect skin cancers … We used terms skin neoplasms, squamous cell neoplasms, basal cell neoplasms, melanoma , and mass screening … on case patients ( n = 650) in Berwick and colleagues' study 7 were obtained from the Connecticut Tumor … with whole-body examination by primary care clinicians or by self-examination accurately detect skin cancers

177. Diagnostic error in pediatric cancer. | PSNet
     psnet.ahrq.gov/issue/diagnostic-error-pediatric-cancer
     November 16, 2022 - Study Diagnostic error in pediatric cancer. … Diagnostic Error in Pediatric Cancer. … Diagnostic Error in Pediatric Cancer. … June 10, 2018 Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis … September 7, 2016 Safety and diagnostic accuracy of tumor biopsies in children with cancer

178. Chemoprevention of Breast Cancer - Recommendations and Rationale (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
     July 02, 2002 - recommendation The USPSTF found fair evidence that tamoxifen and raloxifene may prevent some breast cancers … average, treating such women with tamoxifen for 5 years would prevent about 3 times as many invasive cancers … women enrolled in BCPT, the women in these trials were younger, had more estrogen-receptor-negative cancers … When effective, both raloxifene and tamoxifen were effective only against estrogen receptor-positive tumors … (0.8 cancers/1,000 women taking placebo vs 3.1 cancers/1,000 women taking tamoxifen for a median of

179. Gastric-Cancers-Supplementary-App-E (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-e.xlsx
     June 25, 2025 - E-1. OS LT Table E-1. Overall survival league table Pre-op Fluoro+Plat+Taxane + Post-op Fluoro . . . . . . 0.76 [0.55; 1.05] . . . . . . . . . 1.03 [0.51; 2.09] Periop Fluoro+Plat+Taxane+Antiangio 0.92 [0.55; 1.53] . . . . . . . . . . . . . . 0.95 [0.58; 1.55] 0.92 [0.55; 1.53] Periop Fluoro+Plat+Taxane . 1.05 [0.5…

180. Archived: Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the U.S. Preventive Services Task Force: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/risk-factors-and-other-epidemiologic-considerations-for-cervical-cancer-screening-a-narrative-review-for-the-us-preventive-services-task-force/cervical-cancer-screening-2012
     October 15, 2011 - ICC up to age 30 years 47 ; however, there was still uncertainty about its effect on advanced-stage tumors … There was no difference in the aggressiveness of invasive cancers in older women. … Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective … Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) — United States, 2004 … Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial